跳轉至內容
Merck
  • Comparative in vitro anti-hepatitis C virus activities of a selected series of polymerase, protease, and helicase inhibitors.

Comparative in vitro anti-hepatitis C virus activities of a selected series of polymerase, protease, and helicase inhibitors.

Antimicrobial agents and chemotherapy (2008-07-16)
Jan Paeshuyse, Inge Vliegen, Lotte Coelmont, Pieter Leyssen, Oriana Tabarrini, Piet Herdewijn, Harald Mittendorfer, Johnny Easmon, Violetta Cecchetti, Ralf Bartenschlager, Gerhard Puerstinger, Johan Neyts
摘要

We report here a comparative study of the anti-hepatitis C virus (HCV) activities of selected (i) nucleoside polymerase, (ii) nonnucleoside polymerase, (iii) alpha,gamma-diketo acid polymerase, (iv) NS3 protease, and (v) helicase inhibitors, as well as (vi) cyclophilin binding molecules and (vii) alpha 2b interferon in four different HCV genotype 1b replicon systems.

材料
產品編號
品牌
產品描述

Sigma-Aldrich
环孢菌素A, 97.0-101.5% (on dried basis)
Sigma-Aldrich
环孢菌素A, from Tolypocladium inflatum, ≥95% (HPLC), solid
Sigma-Aldrich
环孢菌素A, from Tolypocladium inflatum, BioReagent, for molecular biology, ≥95%
Sigma-Aldrich
2-噻吩甲酸, ReagentPlus®, 99%
Supelco
环孢菌素A, VETRANAL®, analytical standard